Articles tagged with Doctor-Industry Ties

Tags > D > Doctor-Industry Ties

Articles Tagged With 'Doctor-Industry Ties'

Reports Show Weaknesses in Oversight of Clinical Trials

by Alexandra Andrews, ProPublica - April 2, 2009 4:21 pm EDT

Millions of Americans enroll in clinical trials for experimental drugs and medical devices every year, essentially putting their well … more

Wyeth Funded Med School Course Promoting Risky Drugs

by Alexandra Andrews, ProPublica - January 26, 2009 4:46 pm EDT

Wyeth's impending sale to Pfizer landed it in headlines nationwide today, but a little-noticed article in yesterday's Milwaukee Journ … more

Scrutiny of Doctor-Pharma Ties Leads to Change

by Alexandra Andrews, ProPublica - January 16, 2009 5:35 pm EDT

This past weekend, the Milwaukee Journal Sentinel published a slew of articles about dozens of doctors at the University of Wisconsin … more

ProPublica Report

Enter your e-mail address
to receive our top stories daily.

Breaking on the Web: Doctor-Industry Ties

March 15, 2010

Drug Firms Turn to Private Physicians to Promote Products John Fauber, Journal-Sentinel, March 15, 2010

December 28, 2009

Medical Sales Reps Work Alongside Doctors, Even in Operating Rooms David S. Hilzenrath, Washington Post, December 28, 2009

December 24, 2009

Med. Journal Editor Gets Royalties as Articles Favor Devices John Fauber, Milwaukee Journal Sentinel, December 24, 2009

September 29, 2009

60 Mass. Doctors Took Speaker Fees From Drug Giant Liz Kowalczyk, Boston Globe, September 29, 2009

September 23, 2009

Eli Lilly Paid Florida Doctors to Discuss Drugs Bob LaMendola and Fernando Quintero, Orlando Sentinel, September 23, 2009

September 11, 2009

Study: Ghostwriting Is Rife in Medical Journals Duff Wilson and Natasha Singer, New York Times, September 11, 2009

More...


© Copyright 2010 Pro Publica Inc.

FREE REPRINTS

 Unless otherwise noted, you can republish our articles and graphics (but not our photographs) for free. You just have to credit us and link to us, and you can’t edit our material or sell it separately. (We're licensed under Creative Commons, which provides the legal details.)